Brain MRI correlates of cognitive dysfunction in type 2 diabetes: The needle recovered from the haystack?

Diabetes Care

Volumn 36, Issue 12, 2013, Pages 3855-3856

  Biessels, Geert Jan ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AGING; ALZHEIMER DISEASE; ATTRIBUTABLE RISK; BRAIN ATROPHY; COGNITIVE DEFECT; DEMENTIA; DISEASE ASSOCIATION; HIGH RISK POPULATION; HUMAN; MENTAL TEST; NEUROPATHOLOGY; NON INSULIN DEPENDENT DIABETES MELLITUS; NOTE; NUCLEAR MAGNETIC RESONANCE IMAGING; WHITE MATTER LESION; BRAIN; CEREBROVASCULAR DISORDERS; COGNITION; COMPLICATION; FEMALE; MALE; PATHOLOGY; PHYSIOLOGY;

BRAIN; CEREBROVASCULAR DISORDERS; COGNITION; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE;

EID: 84891875514     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc13-1501     Document Type: Note

References (25)

1. Biessels GJ, Staekenborg S, Brunner E, Brayne C, Scheltens P. Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol 2006;5:64-74
2. Cheng G, Huang C, Deng H, Wang H. Diabetes as a risk factor for dementia and mild cognitive impairment: a metaanalysis of longitudinal studies. Intern Med J 2012;42:484-491
3. Centers for Disease Control and Prevention. National Diabetes Fact Sheet, 2011 [Internet], 2013. Available from http://www.cdc.gov/diabetes/pubs/pdf/ ndfs- 2011.pdf. Accessed June 2013
4. Marchesi VT. Alzheimer's disease 2012: the great amyloid gamble. Am J Pathol 2012;180:1762-1767
5. O'Brien JT, Erkinjuntti T, Reisberg B, et al. Vascular cognitive impairment. Lancet Neurol 2003;2:89-98
6. Schneider JA, Bennett DA. Where vascular meets neurodegenerative disease. Stroke 2010;41(Suppl.):S144-S146
7. Stern Y. Cognitive reserve in ageing and Alzheimer's disease. Lancet Neurol 2012; 11:1006-1012
8. Moran C, Phan TG, Chen J, et al. Brain atrophy in type 2 diabetes: regional distribution and influence on cognition. Diabetes Care 2013;36:4036-4042
9. Manschot SM, Brands AM, van der Grond J, et al.; Utrecht Diabetic Encephalopathy Study Group. Brain magnetic resonance imaging correlates of impaired cognition in patients with type 2 diabetes. Diabetes 2006;55:1106-1113
10. Espeland MA, Bryan RN, Goveas JS, et al.; WHIMS-MRI Study Group. Influence of type 2 diabetes on brain volumes and changes in brain volumes: results from the Women's Health Initiative Magnetic Resonance Imaging studies. Diabetes Care 2013;36:90-97
11. Falvey CM, Rosano C, Simonsick EM, et al. Macro-and microstructural magnetic resonance imaging indices associated with diabetes among community-dwelling older adults. Diabetes Care 2013;36:677-682
12. Saczynski JS, Siggurdsson S, Jonsson PV, et al. Glycemic status and brain injury in older individuals: the age gene/environment susceptibility-Reykjavik study. Diabetes Care 2009;32:1608-1613
13. van den Berg E, Kloppenborg RP, Kessels RP, Kappelle LJ, Biessels GJ. Type 2 diabetes mellitus, hypertension, dyslipidemia and obesity: a systematic comparison of their impact on cognition. Biochim Biophys Acta 2009;1792:470-481
14. Reijmer YD, van den Berg E, Ruis C, Kappelle LJ, Biessels GJ. Cognitive dysfunction in patients with type 2 diabetes. Diabetes Metab Res Rev 2010;26:507-519
15. van den Berg E, Reijmer YD, de Bresser J, Kessels RP, Kappelle LJ, Biessels GJ; Utrecht Diabetic Encephalopathy Study Group. A 4-year follow-up study of cognitive functioning in patients with type 2 diabetes mellitus. Diabetologia 2010;53:58-65
16. Yaffe K, Falvey C, Hamilton N, et al. Diabetes, glucose control, and 9-year cognitive decline among older adults without dementia. Arch Neurol 2012;69:1170-1175
17. de Bresser J, Tiehuis AM, van den Berg E, et al.; Utrecht Diabetic Encephalopathy Study Group. Progression of cerebral atrophy and white matter hyperintensities in patients with type 2 diabetes. Diabetes Care 2010;33:1309-1314
18. Chan D, Janssen JC, Whitwell JL, et al. Change in rates of cerebral atrophy over time in early-onset Alzheimer's disease: longitudinal MRI study. Lancet 2003; 362:1121-1122
19. Ridha BH, Barnes J, Bartlett JW, et al. Tracking atrophy progression in familial Alzheimer's disease: a serial MRI study. Lancet Neurol 2006;5:828-834
20. van Harten B, de Leeuw FE, Weinstein HC, Scheltens P, Biessels GJ. Brain imaging in patients with diabetes: a systematic review. Diabetes Care 2006;29:2539-2548
21. Pantoni L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol 2010;9:689-701
22. Reijmer YD, Leemans A, Brundel M, Kappelle LJ, Biessels GJ; Utrecht Vascular Cognitive Impairment (VCI) Study Group. Disruption of the cerebral white matter network is related to slowing of information processing speed in patients with type 2 diabetes. Diabetes 2013;62: 2112-2115
23. Ahtiluoto S, Polvikoski T, Peltonen M, et al. Diabetes, Alzheimer disease, and vascular dementia: a population-based neuropathologic study. Neurology 2010;75:1195-1202
24. Jack CR Jr. Alliance for aging research AD biomarkers work group: structural MRI. Neurobiol Aging 2011;32(Suppl. 1):S48-S57
25. Jagust WJ, Zheng L, Harvey DJ, et al. Neuropathological basis of magnetic resonance images in aging and dementia. Ann Neurol 2008;63:72-80